Reuters logo
3 个月内
BRIEF-Revance reports Q1 loss per share $0.94
2017年5月9日 / 晚上9点29分 / 3 个月内

BRIEF-Revance reports Q1 loss per share $0.94

1 分钟阅读

May 9 (Reuters) - Revance Therapeutics Inc

* Revance releases first quarter 2017 results

* Revance Therapeutics Inc - qtrly loss per share $0.94

* Revance therapeutics inc says reaffirmed its financial guidance provided in January 2017

* Revance Therapeutics Inc says expects cash burn for 2017 to be in range of $102 to $112 million

* Revance Therapeutics Inc says expects 2017 GAAP operating expense to be in range of $108 to $119 million Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below